Home > Healthcare > Healthcare IT > Telehealth > Telepharmacy Market

Telepharmacy Market Size

  • Report ID: GMI12100
  • Published Date: Nov 2024
  • Report Format: PDF

Telepharmacy Market Size

The global telepharmacy market size was valued at USD 9.9 billion in 2023 and is estimated to grow at a CAGR of 10.4% from 2024 to 2032. Telepharmacy refers to the use of telecommunications technology to provide pharmaceutical care remotely. This practice enables pharmacists to deliver services such as medication counseling, prescription verification, and patient monitoring without requiring in-person visits. Telepharmacy enhances access to pharmaceutical services, especially in underserved areas, and allows for more efficient medication management.

 

The market is witnessing significant growth fueled by the increasing need for accessible healthcare solutions, particularly in rural and underserved areas where pharmacy services are limited. Telepharmacy enables patients to receive prescriptions, counseling, and medication management from licensed pharmacists through digital platforms, improving convenience and reducing travel burdens. The COVID-19 pandemic accelerated telepharmacy adoption as healthcare providers sought safe, remote care solutions.
 

For instance, according to a January 2022 article titled "Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic," published in Europe PMC, patients with telepharmacy access experienced a reduced rise in hospitalization rates compared to those without access, highlighting the impact of telepharmacy on outpatient care during COVID-19. The pandemic positively influenced the telepharmacy market, as healthcare providers sought alternatives for safe, remote patient interaction. Additionally, the market is projected to grow further, supported by the global rise in smartphone usage, which facilitates easy access to telepharmacy services for a broader patient base.
 

Furthermore, technological advancements, such as secure video conferencing and digital health records, further support telepharmacy growth by enhancing patient engagement and healthcare efficiency.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global telepharmacy industry was valued at USD 9.9 billion in 2023 and is estimated to grow at a 10.4% CAGR from 2024 to 2032, driven by the increasing need for remote pharmaceutical care.

The software segment dominated the market in 2023 and is anticipated to grow at a 10.7% CAGR over the forecast period due to the rising demand for robust platforms supporting remote consultations, prescription management, and patient monitoring.

In 2023, the U.S. held a leading position in the North American market and is projected to maintain this dominance throughout the forecast period, with a CAGR of 10.1%, driven by advanced healthcare infrastructure and high adoption of digital health solutions.

Key players in the telepharmacy sector include AZOVA, Cardinal Health, CarepathRx, CPS Solutions, Indispensable Health, Infinipharm, Medication Review, OSP, Outcomes, PipelineRx, and Right ePharmacy.

Telepharmacy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 120
  • Countries covered: 19
  • Pages: 140
 Download Free Sample